Alicia Irurzun-Lafitte
Inversor de Capital Privado en UCB Ventures (Private Equity) .
Perfil
Alicia Irurzun-Lafitte joined UCB Ventures in March 2019 as Partner.
Alicia joined from M Ventures, the corporate venture arm of Merck KGaA.
Since 2014, she was instrumental in the closing of multiple new investments in Oncology, Immunology and Fertility areas in the US and Europe for the M Ventures Healthcare fund.
Alicia was also closely involved with the built-up of Merck spin-offs.
While at M Ventures, she served on the Board of Rewind Therapeutics as Director and Artios, iOnctura, Ribometrix, and TocopheRx as Observer.
Prior to ventures, Alicia held roles in global business development at Merck Serono in Geneva and EMD Serono in Boston.
During her time in business development she closed multiple early stage transactions and was involved in strategic corporate development initiatives.
Alicia holds a MSc from Leiden University in Biopharmaceutical Sciences.
She holds a Bachelor in Biomedical Sciences and completed her undergraduate studies between the University Claude Bernard Lyon 1 and Napier Edinburgh University.Alicia is based at the UCB Ventures’ Boston office and she lives in New York.
Cargos activos de Alicia Irurzun-Lafitte
Empresas | Cargo | Inicio |
---|---|---|
UCB Ventures (Private Equity)
UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom. | Inversor de Capital Privado | - |
Antiguos cargos conocidos de Alicia Irurzun-Lafitte.
Empresas | Cargo | Fin |
---|---|---|
Merck Ventures (USA) | Inversor de Capital Privado | 06/03/2019 |
TocopheRx, Inc.
TocopheRx, Inc. Medical SpecialtiesHealth Technology TocopheRx, Inc. developed novel therapies for treatment of infertility. The company was founded by Stephen Palmer, Selva Nataraja, and Henry Yu on December 2, 2013 and was headquartered in Gorton, MA. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
TocopheRx, Inc.
TocopheRx, Inc. Medical SpecialtiesHealth Technology TocopheRx, Inc. developed novel therapies for treatment of infertility. The company was founded by Stephen Palmer, Selva Nataraja, and Henry Yu on December 2, 2013 and was headquartered in Gorton, MA. | Health Technology |
Merck Ventures (USA) | Finance |
UCB Ventures (Private Equity)
UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom. | Finance |
- Bolsa de valores
- Insiders
- Alicia Irurzun-Lafitte